ETAILS Medanta, DLF To Launch 400-Bed Hospital In South Delhi

New Delhi : Global Health Limited will launch a 400-bed multi-super specialty hospital in Delhi in association with real estate developer DLF, the private healthcare provider said on Thursday.

The super speciality hospital is slated to provide cutting-edge medical and surgical interventions in over 20 super specialties, including Cardiac sciences, Neurosciences, Orthopaedics, Kidney, Liver, Lung and Heart Transplants, Gastroenterology, and Chest Surgery, the company said in a statement.

The facility will also have a Comprehensive Cancer Care unit, offering end-to-end oncology treatments under one roof. This new facility will strengthen Medanta’s presence in the National Capital Region of Delhi. Medanta will operate its Gurugram, Noida, and Delhi facilities in a seamless manner linking its existing 1,391-bed flagship hospital in Gurugram and its upcoming Noida facility (550 beds) to the new hospital in South Delhi.

“Our new hospital will bring the best of Medanta’s renowned clinical expertise and patient care closer to the people of Delhi. It will offer cutting-edge surgical treatments across specialties under one roof with the same patient quality safety standards that Medanta has come to be known for. It will also become a one-stop solution for all types of cancer treatments and will benefit a large swathe of patients not only in Delhi but across Uttar Pradesh, Haryana, Rajasthan, and other neighbouring states,” Dr. Naresh Trehan, Chairman and Managing Director of Global Health Limited, said.

Both Medanta and DLF will hold equal 50% equity in the new company, which is set to inaugurate the upcoming hospital in Greater Kailash (GK), South Delhi. DLF will serve as a strategic investor, while Medanta will assume operational control of the hospital, as stated by Global Health Limited in a regulatory filing.

“The new hospital will strengthen the medical infrastructure in Delhi and further strengthen DLF’s deep commitment to improving the quality of life for NCR residents,” Rajiv Singh, Chairman of DLF Ltd said.

Related Posts

  • Pharma
  • July 15, 2025
  • 100 views
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharmaceutical Industries Ltd has announced that it has entered into a settlement and license agreement with Incyte Corporation regarding litigation related to LEQSELVI (deuruxolitinib). “Under the terms of agreement,…

  • Pharma
  • July 15, 2025
  • 114 views
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR